Sue Carter is executive director of the Kinsey Institute at Indiana University.
Sue Carter
Executive director
Kinsey Institute, Indiana University
From this contributor
Oxytocin’s power
A new study shows that long-term treatment with oxytocin, a hormone that typically enhances social bonds, can have unexpected consequences, says Sue Carter, a research scientist at RTI International.
Explore more from The Transmitter
After NINDS director ouster, 40 neuroscience organizations press U.S. Congress for oversight over hiring process
A letter signed by the groups asks Congress to ensure that scientific expertise remains a priority in the search for a new director of the National Institute of Neurological Disorders and Stroke.
After NINDS director ouster, 40 neuroscience organizations press U.S. Congress for oversight over hiring process
A letter signed by the groups asks Congress to ensure that scientific expertise remains a priority in the search for a new director of the National Institute of Neurological Disorders and Stroke.
BRAIN Initiative researchers ‘dream big’ amid shifts in leadership, funding
But whether the initiative’s road map for the next decade is feasible remains an open question.
BRAIN Initiative researchers ‘dream big’ amid shifts in leadership, funding
But whether the initiative’s road map for the next decade is feasible remains an open question.
Neuroscience, BRAIN Initiative gain budget in ‘bad’ NIH funding bill
The bill goes before the House of Representatives today and outlines increases for neuroscience-related research—including a 33 percent increase to the BRAIN Initiative—but maintains a multiyear spending approach that could limit the number of grants awarded overall.
Neuroscience, BRAIN Initiative gain budget in ‘bad’ NIH funding bill
The bill goes before the House of Representatives today and outlines increases for neuroscience-related research—including a 33 percent increase to the BRAIN Initiative—but maintains a multiyear spending approach that could limit the number of grants awarded overall.